Document Type

Article

Publication Date

2-26-2018

Comments

This article has been peer reviewed. It is the author’s final published version in International Journal of Retina and Vitreous, Volume 4, Issue 1, February 2018, Article number 9.

The published version is available at https://doi.org/10.1186/s40942-018-0112-4. Copyright © McGarrey et al.

Abstract

Background: Precise, submillimeter visualization of retinal microstructures is useful for treatment monitoring of retinoblastoma. Herein, we report the use of hand-held optical coherence tomography (HH-OCT) to document a nearly-invisible retinoblastoma and monitor tumor response to transpupillary thermotherapy (TTT). Case presentation: A 3-week-old boy was diagnosed with unilateral familial retinoblastoma in the left eye, classified as group B, and treated with intravenous chemoreduction. At 13-month follow-up, the tumor in the left eye was regressed, and evaluation of the right eye revealed a microscopic, nearly invisible tumor measuring 372 μm in thickness and 1.51 mm in basal dimension. The tumor was confirmed on HH-OCT and the diagnosis was changed to bilateral familial retinoblastoma. The new tumor was subsequently treated with TTT and after 1 month, the tumor regressed to an optically dense scar 166 μm in thickness by HH-OCT. Five months after TTT, the scar was clinically flat and measured 73 μm. Conclusions: HH-OCT has assumed a significant role in the monitoring of retinoblastoma in children. In this case, imaging with HH-OCT allowed precise localization of the tumor and submillimeter monitoring of treatment response following TTT. © The Author(s) 2018.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Language

English

Download

Included in

Ophthalmology Commons

Share

COinS